Bazelet Oglesby enters the Georgia cannabis market with its patented, THC free Panakeia plants
By: Neon Bloom, Inc
Following the company's rural development initiatives, its first crop, located in Southwest Georgia , is the adaptive reuse of the former Green Valley Country Club. The site is one of several in Georgia that the Company will utilize to produce its 2021 Panakeia crop.
Panakeia is the first (USPTO) patented cannabis plant in the world. Panakeia plants contain 0.00% Tetrahydrocannabinol (THC) an illegal substance under federal law that is found in all marijuana and hemp plants. Panakeia plants have the most promising of all cannabinoids for broad use in food, drug and cosmetic applications. Bazelet is the licensed patent, trademark and manufacturer of Panakeia and first-to-market in the development and innovation of THC-Free cannabis ingredients.
Called by some, the Tesla of cannabis, Bazelet built Panakeia plants allow access to the diverse and therapeutic compounds found in cannabis but with zero risk of breaking federal law and zero risk of unwanted intoxication from THC.
"Bazelet Oglesby is one of only a few companies positioned to establish legal cannabis as a respected, sustainable industry. We are honored and accept with responsibility, that we are part of authoring its history and excited to serve the Georgia market." Said Gary Hennen , Director with Bazelet Oglesby.
Bazelet Chief Medical Officer Dr. Francisco Ward commented that " Georgia is expected to soon launch a new, low THC medical marijuana program. Bazelet is uniquely positioned to provide Georgia's healthcare professionals exceptional cannabinoid derived products that are safe, effective and made from the world's only 0.00% THC cannabis plant collection".
About Bazelet Oglesby:
An innovative plant science company establishing itself as a world leader in tissue culture propagation and the production of young plants for the global horticulture industry.
This Press Release is for informational purposes, contains forward-looking statements based on current expectations, forecasts, and assumptions with information available to us as of the date hereof and involve risks and uncertainties. This Press Release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. Actual results may differ materially from those stated or implied in such forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate,"